Graphite Bio Inc

-0.07 (-2.97%)
Earnings Announcements

Graphite Bio Reports Q1 2022 Financial Results

Published: 05/12/2022 21:21 GMT
Graphite Bio Inc (GRPH) - Graphite Bio Reports Recent Business Progress and First Quarter 2022 Financial Results.
Graphite Bio - $352.1 Million in Cash, Cash Equivalents and Investments in Marketable Securities As of March 31, 2022; Cash Runway Into Q4 of 2024.
Qtrly Net Loss per Common Share - Basic and Diluted $0.48.
Q1 Earnings per Share View $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.